An abundant merozoite surface protein of Plasmodium falciparum modulates susceptibility to inhibitory antibodies
Authors:
- Isabelle G HenshallIHIsabelle G Henshall
- Jill ChmielewskiJCJill Chmielewski
- Dimuthu AngageDADimuthu Angage
- Ornella RomeoOROrnella Romeo
- Keng Heng LaiKLKeng Heng Lai
- Kaitlin R TurlandKTKaitlin R Turland
- Nicki BadiiNBNicki Badii
- Michael FoleyMFMichael Foley
- Robin F AndersRARobin F Anders
- James G BeesonJBJames G Beeson
- Danny W WilsonDWDanny W Wilson
Open Access
- 27 July 2026
- journal article
- research article
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 14
Abstract
Malaria merozoite surface proteins (MSPs) are thought to have important roles in red blood cell (RBC) invasion and their exposure on the parasite surface makes them attractive vaccine candidates. However, their role in invasion has not been directly demonstrated and their biological functions remain unknown. One of the most abundant merozoite surface proteins is Pf MSP2, a likely ancestral protein that has been maintained in the Plasmodium falciparum lineage and is a focus of vaccine development. Using CRISPR-Cas9 gene editing, we removed Pf MSP2 from two different P. falciparum lines with no impact on parasite replication or phenotype in vitro, demonstrating that it is not essential for RBC invasion. Interestingly, loss of Pf MSP2 led to increased inhibitory potency of antibodies targeting other merozoite proteins involved in invasion, particularly Pf AMA1. In a solid-phase model, increasing concentrations of Pf MSP2 protein reduced binding of different antibodies against Pf AMA1 in a dose-dependent manner. These data suggest that Pf MSP2 can modulate the susceptibility of merozoites to protective inhibitory antibodies. The results of this study change our understanding of the potential functions of Pf MSP2 and establish a new concept in malaria where a surface protein can reduce the protective efficacy of antibodies targeting a different antigen. These findings have important implications for understanding malaria immunity and informing vaccine development.Keywords
All Related Versions
Funding Information
- Australian Research Council (FT240100420)
- Hospital Research Foundation (C-MCF-52-2019)
- Hospital Research Foundation (S-03-EOI-2021)
- National Health and Medical Research Council (2033320)
- National Health and Medical Research Council (1134989)
- Australian Research Council (RTP Scholarship)
This publication has 81 references indexed in Scilit:
- Effects of intrinsically disordered regions in gp120 underlying HIV neutralization phenotypesBiochemical and Biophysical Research Communications, 2024
- Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing AntibodiesCell, 2019
- Interaction of merozoite surface protein 2 with lipid membranesFEBS Letters, 2018
- ggplot22016
- Processing of Plasmodium falciparum Merozoite Surface Protein MSP1 Activates a Spectrin-Binding Function Enabling Parasite Egress from RBCsCell Host & Microbe, 2015
- Lipid interactions of the malaria antigen merozoite surface protein 2Biochimica et Biophysica Acta (BBA) - Biomembranes, 2012
- Identification of key residues involved in fibril formation by the conserved N-terminal region of Plasmodium falciparum merozoite surface protein 2 (MSP2)Biochimie, 2010
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Prediction of Potential GPI-modification Sites in Proprotein SequencesJournal of Molecular Biology, 1999
- Structure and development of the surface coat of erythrocytic merozoites of Plasmodium knowlesiCell and tissue research, 1986